MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines

Hyun-Min Ryu(University of Ulsan), Ki Hyeong Lee(University of Ulsan)

Research Square

April 10, 2025

10.21203/rs.3.rs-5661974/v1

Cited by 0

Related Papers

MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines

|Cellular and Molecular Life Sciences|2025|0